Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials - Concepedia

Concepedia

Publication | Closed Access

Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials

92

Citations

23

References

1993

Year

Ulrich Keilholz, Carmen Scheibenbogen, Wolfgang Tilgen, Lothar Bergmann, Eckardt Weidmann, E. Seither, Max Richter, Bernadett Brado, Paris S. Mitrou, W. Hunstein

Abstract

Toxicity of IL-2 is reduced by modifying the schedule of administration, which also enhances the immunologic response and appears to increase the response rate.

References

	Year	Citations

Page 1